Scaling to New Heights

Scaling to New Heights

View eBook Successfully scaling up monoclonal antibody (mAb) production can be a significant challenge. As workflows scale toward clinical and commercial production volumes, developers need to be confident that a process that works at small scales can be scaled up seamlessly. Maintaining product quality and maximizing productivity while staying economically feasible for long-term production is essential as failures or unexpected outcomes can res…